Navigation Links
Champions Oncology Reports Fiscal 2012 First Quarter Financial Results
Date:9/13/2011

d," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2011 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law. Champions Oncology, Inc.Reconciliation of GAAP to Non-GAAP Net Loss(Amounts in millions except for loss per share amounts)Three Months Ended
July 31,20112010Net loss attributable to Champions – GAAP($2.04)($0.59)Less:Stock-based compensation1.010.17Net loss attributable to Champions-non-GAAP:($1.03)($0.42)Net loss per common share attributable to Champions – non GAAP:Basic and diluted($0.02)($0.02)CONTACT:
Joel Ackerman
Champions Oncology, Inc.
+1-410-369-0365


'/>"/>
SOURCE Champions Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
2. Champions Biotechnology Exercises Option to License Proprietary Compound Based on Successful Tumorgraft™ Test Results
3. Champions CFO Resigns
4. Champions Biotechnology Awarded $1.46 million in Grants
5. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
6. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
7. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
8. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
9. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Japan , July 30, 2015 ... of the study to fulfill the post-marketing commitment ... the Pan European Multi-Database Bladder Cancer Risk ... retrospective matched cohort study, conducted in four European ... HCI) with up to 10 years of follow-up. ...
(Date:7/30/2015)... Calif. , July 30, 2015   ... to eliminate all preventable hospitalization, recently received confirmation ... its Remote Patient Intelligence (RPI) solution meets the ... FDA intends to exercise "Enforcement Discretion." ... not subject to further FDA regulatory requirements at ...
(Date:7/30/2015)... July 30, 2015  Lannett Company, Inc. (NYSE: ... at the Canaccord Genuity 35th Annual Growth Conference on ... the InterContinental Boston Hotel.  A webcast ... .  Listeners are encouraged to visit the web site ... the presentation to register, download and install any necessary ...
Breaking Medicine Technology:Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
... YORK, June 20, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0558499/Top-Medical-Devices-and-Imaging-Technologies-2011.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices ... device and imaging technologies that have excellent ...
... VANCOUVER, British Columbia, June 17, 2011 Abattis Biologix Corporation ... commenced trading on the OTC Pink Sheets under the symbol ... the company proceeds with financing activities and the preparation of ... and other exchanges. Mike Withrow, CEO of Ab ...
Cached Medicine Technology:Reportlinker Adds Top Medical Devices and Imaging Technologies 2011 2Abattis Biologix Corporation Begins Trading on Pink Sheets 2
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is a New Way ... Training Capability , World renown body weight trainer, Paul Ziachik, announces today ... dramatically increases a person’s training capability. , The American College of Sports Medicine ...
(Date:7/30/2015)... ... 30, 2015 , ... Boston Web Marketing is ... Google Partners is the platform for search marketing agencies to communicate with the ... necessary to run successful search marketing campaigns. Google Partners also affords businesses the ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Gummy smile ... lip lowering, gum contouring and surgery, as well as the patented gum depigmentation treatmet. ... has made him popular with many patients from around the world. , “Like treatment ...
(Date:7/30/2015)... ... ... InventHelp, a leading inventor service company, announces that one of ... easy to apply lotion or medication to a hard-to-reach area. This invention is patented. ... medication to the back, and provides thorough coverage. The product would prevent the user ...
(Date:7/30/2015)... ... July 30, 2015 , ... After conducting a nationwide executive search ... Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh as Chief ... 25 years of healthcare leadership experience, Walsh is an expert in organizational change, physician ...
Breaking Medicine News(10 mins):Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5
... American Speech-Language-Hearing Association (ASHA) has announced plans to award ... of the Association for her pioneering research and academic ... Chair in Communication Disorders in the School of Behavioral ... research in the Callier Center for Communication Disorders. In ...
... INDIANAPOLIS Technologies for rapid detection of bacterial ... supply. Researchers from the School of ... the Bindley Bioscience Center at Purdue University have ... classification of harmful bacteria in food. The investigators ...
... in the Oct. 15 issue of the Journal of ... a much higher prevalence and risk of restless legs syndrome ... may improve sleep and quality of life in people with ... syndrome was about 10 times higher in the fibromyalgia group ...
... precursors of all the tissues in our body, can ... cancer. Now research from Rockefeller University shows that having ... for too long, can increase the odds of developing ... death in precursor cells for blood, or hematopoietic stem ...
... known as beta blockers have been proven to increase patients, ... workload and oxygen demand on the heart. In a breakthrough ... Medicine cardiologist Jeffrey J. Goldberger found the majority of patients ... drugs, which can put their recovery from heart attacks and ...
... HealthDay Reporter , THURSDAY, Oct. 14 (HealthDay News) ... follows all the recommended colon cancer screening guidelines, a new ... for some tests, while the remaining 40 percent don,t follow ... "There,s more work to be done to understand how to ...
Cached Medicine News:Health News:Award to honor pivotal career in speech research 2Health News:Award to honor pivotal career in speech research 3Health News:Eat safer: Novel approach detects unknown food pathogens 2Health News:Study finds a high rate of restless legs syndrome in adults with fibromyalgia 2Health News:Gene identified that prevents stem cells from turning cancerous 2Health News:Gene identified that prevents stem cells from turning cancerous 3Health News:Low beta blocker dose can put patients at risk for subsequent heart attacks 2Health News:Most Doctors Don't Follow Colon Cancer Screening Guidelines 2Health News:Most Doctors Don't Follow Colon Cancer Screening Guidelines 3
... implanted bone growth stimulator for the treatment ... implanted bone growth stimulator is a useful ... surgery is already planned or when patient ... OsteoGen is totally surgically implanted, patients are ...
... Stryker is proud to offer ... on the market at only ... design incorporates a superior flow ... intuitive locking mechanisms. The complementing ...
... Cryocare® CS is ... placement and treatment system ... and allow unlimited flexibility. ... to meet specific physician ...
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips....
Medicine Products: